Hepatitis e virus infection

Current Opinion in Gastroenterology

Volumn 29, Issue 3, 2013, Pages 271-278

  Kamar, Nassim ^a,b,c   Izopet, Jacques ^b,c   Rostaing, Lionel ^a,b,c  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

chronic infection; cirrhosis; extrahepatic symptoms; hepatitis E virus; ribavirin

Indexed keywords

PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

ANTIVIRAL THERAPY; APLASTIC ANEMIA; AUTOLOGOUS STEM CELL TRANSPLANTATION; CHRONIC LIVER DISEASE; CRYOGLOBULINEMIA; DEVELOPING COUNTRY; ENZYME IMMUNOASSAY; GENOTYPE; GUILLAIN BARRE SYNDROME; HEMATOLOGIC DISEASE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MEMBRANOUS GLOMERULONEPHRITIS; MONOTHERAPY; NEUROLOGIC DISEASE; ORGAN TRANSPLANTATION; PANCREATITIS; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; REVIEW; SYMPTOM; THROMBOCYTOPENIA; VIRUS TRANSMISSION;

CHRONIC DISEASE; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HEMATOLOGIC DISEASES; HEPATITIS E; HIV INFECTIONS; HUMANS; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION;

EID: 84876207200     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32835ff238     Document Type: Review

References (120)

1. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet 2012; 379:2477-2488.
2. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8:698-709.
3. Said B, Ijaz S, Kafatos G, et al. Hepatitis E outbreak on cruise ship. Emerg Infect Dis 2009; 15:1738-1744.
4. Meng XJ. From barnyard to food table: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety. Virus Res 2011; 161:23-30.
5. Hakze-van der Honing RW, van Coillie E, Antonis AF, van der Poel WH. First isolation of hepatitis E virus genotype 4 in Europe through swine surveillance in the Netherlands and Belgium. PLoS One 2011; 6:e22673.
6. Purcell RH, Engle RE, Rood MP, et al. Hepatitis E virus in rats, Los Angeles, California, USA. Emerg Infect Dis 2011; 17:2216-2222.
7. Lack JB, Volk K, Van Den Bussche RA. Hepatitis E virus genotype 3 in wild rats, United States. Emerg Infect Dis 2012; 18:1268-1273.
8. Feagins AR, Opriessnig T, Guenette DK, et al. Detection and characterization of infectious hepatitis E virus from commercial pig livers sold in local grocery stores in the USA. J Gen Virol 2007; 88 (Pt 3):912-917.
9. Colson P, Borentain P, Queyriaux B, et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010; 202:825-834.
10. Mansuy JM, Bendall R, Legrand-Abravanel F, et al. Hepatitis E virus antibody in blood donors, France. Emerg Infect Dis 2011; 17:2309-2312.
11. Berto A, Martelli F, Grierson S, Banks M. Hepatitis E virus in pork food chain, United Kingdom, 2009-2010. Emerg Infect Dis 2012; 18:1358-1360.
12. Johne R, Plenge-Bonig A, Hess M, et al. Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad-spectrum RT-PCR. J Gen Virol 2010; 91 (Pt 3):750-758.
13. Takahashi M, Nishizawa T, Sato H, et al. Analysis of the full-length genome of a hepatitis E virus isolate obtained from a wild boar in Japan that is classifiable into a novel genotype. J Gen Virol 2011; 92:902-908.
14. Zhao C, Ma Z, Harrison TJ, et al. A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J Med Virol 2009; 81:1371-1379.
15. Izopet J, Dubois M, Bertagnoli S, et al. Hepatitis E virus strains in rabbits and evidence of a closely related strain in humans, France. Emerg Infect Dis 2012; 18:1274-1281.
16. Cossaboom CM, Cordoba L, Cao D, et al. Complete genome sequence of hepatitis E virus from rabbits in the United States. J Virol 2012; 86:13124-13125.
17. Raj VS, Smits SL, Pas SD, et al. Novel hepatitis E virus in ferrets, the Netherlands. Emerg Infect Dis 2012; 18:1369-1370.
18. Drexler JF, Seelen A, Corman VM, et al. Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae. J Virol 2012; 86:9134-9147.
19. Mitsui T, Tsukamoto Y, Yamazaki C, et al. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol 2004; 74:563-572.
20. Khuroo MS, Kamili S, Yattoo GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 2004; 19:778-784.
21. Tamura A, Shimizu YK, Tanaka T, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007; 37:113-120.
22. Matsubayashi K, Nagaoka Y, Sakata H, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004; 44:934-940.
23. Haim-Boukobza S, Ferey MP, Vetillard AL, et al. Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol 2012; 57:1374-1378.
24. Ayoola EA, Want MA, Gadour MO, et al. Hepatitis E virus infection in haemodialysis patients: a case-control study in Saudi Arabia. J Med Virol 2002; 66:329-334.
25. Mansuy JM, Huynh A, Abravanel F, et al. Molecular evidence of patient-to-patient transmission of hepatitis E virus in a hematology ward. Clin Infect Dis 2009; 48:373-374.
26. Khuroo MS, Kamili S, Jameel S. Vertical transmission of hepatitis E virus. Lancet 1995; 345:1025-1026.
27. Bendall R, Ellis V, Ijaz S, et al. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010; 82:799-805.
28. Drobeniuc J, Meng J, Reuter G, et al. Serologic assays specific to immu-noglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010; 51:e24-e27.
29. Mansuy JM, Legrand-Abravanel F, Calot JP, et al. High prevalence of antihepatitis E virus antibodies in blood donors from south west France. J Med Virol 2008; 80:289-293.
30. Rossi-Tamisier M, Moal V, Gerolami R, Colson P. Discrepancy between antihepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients. J Clin Virol 2013; 56:62-64.
31. Carpentier A, Chaussade H, Rigaud E, et al. High hepatitis E virus seropre-valence in forestry workers and in wild boars in France. J Clin Microbiol 2012; 50:2888-2893.
32. Legrand-Abravanel F, Thevenet I, Mansuy JM, et al. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol 2009; 16:772-774.
33. Kamar N, Legrand-Abravanel F, Izopet J, Rostaing L. Hepatitis E virus: what transplant physicians should know. Am J Transplant 2012; 12:2281-2287.
34. Pischke S, Stiefel P, Franz B, et al. Chronic hepatitis E in heart transplant recipients. Am J Transplant 2012; 12:3128-3133.
35. Baylis SA, Hanschmann KM, Blumel J, Nubling CM. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011; 49:1234-1239.
36. Abravanel F, Sandres-Saune K, Lhomme S, et al. Genotype 3 diversity and quantification of hepatitis E virus RNA. J Clin Microbiol 2012; 50:897-902.
37. Hoofnagle JH, Nelson K, Purcell RH. Hepatitis E. N Engl J Med 2012; 367:1237-1244.
38. Labrique AB, Sikder SS, Krain LJ, et al. Hepatitis E, a vaccine-preventable cause of maternal deaths. Emerg Infect Dis 2012; 18:1401-1404.
39. Tsega E, Krawczynski K, Hansson BG, Nordenfelt E. Hepatitis E virus infection in pregnancy in Ethiopia. Ethiop Med J 1993; 31:173-181.
40. Sharapov MB, Favorov MO, Yashina TL, et al. Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data. BMC Infect Dis 2009; 9:35.
41. Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int 2008; 28:1190-1199.
42. Kumar Acharya S, Kumar Sharma P, Singh R, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 2007; 46:387-394.
43. Kuniholm MH, Purcell RH, McQuillan GM, et al. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009; 200:48-56.
44. Faramawi MF, Johnson E, Chen S, Pannala PR. The incidence of hepatitis E virus infection in the general population of the USA. Epidemiol Infect 2011; 139:1145-1150.
45. Boutrouille A, Bakkali-Kassimi L, Cruciere C, Pavio N. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 2007; 45:2009-2010.
46. Bouwknegt M, Engel B, Herremans MM, et al. Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in The Netherlands. Epidemiol Infect 2008; 136:567-576.
47. Kaufmann A, Kenfak-Foguena A, Andre C, et al. Hepatitis E virus seropre-valence among blood donors in southwest Switzerland. PLoS One 2011; 6:e21150.
48. Beale MA, Tettmar K, Szypulska R, et al. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang 2011; 100:340-342.
49. Dalton HR, Fellows HJ, Stableforth W, et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007; 26:1429-1435.
50. Davern TJ, Chalasani N, Fontana RJ, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011; 141:1665-1672.
51. Peron JM, Bureau C, Poirson H, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007; 14:298-303.
52. Dalton HR, Hazeldine S, Banks M, et al. Locally acquired hepatitis E in chronic liver disease. Lancet 2007; 369:1260.
53. De Silva S, Hassan-Ibrahim MO, Austin M, et al. Hepatitis E infection is an under recognized cause of acute decompensation in patients with chronic liver disease. Dig Liver Dis 2012; 44:930-934.
54. Legrand-Abravanel F, Kamar N, Sandres-Saune K, et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010; 202:835-844.
55. Legrand-Abravanel F, Kamar N, Sandres-Saune K, et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011; 17:30-37.
56. Schlosser B, Stein A, Neuhaus R, et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol 2012; 56:500-502.
57. Pischke S, Suneetha PV, Baechlein C, et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010; 16:74-82.
58. Buti M, Cabrera C, Jardi R, et al. Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection? Liver Transpl 2010; 16:106-107.
59. Haagsma EB, Niesters HG, van den Berg AP, et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 2009; 15:1225-1228.
60. Pas SD, de Man RA, Mulders C, et al. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis 2012; 18:869-872.
61. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140:1481-1489.
62. Gerolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008; 358:859-860.
63. Kamar N, Mansuy JM, Cointault O, et al. Hepatitis E virus-related cirrhosis in kidney-and kidney-pancreas-transplant recipients. Am J Transplant 2008; 8:1744-1748.
64. Kamar N, Abravanel F, Selves J, et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 2010; 89:353-360.
65. Halac U, Béland K, Lapierre P, et al. Chronic hepatitis E infection in children with liver transplantation. Gut 2012; 64:597-603.
66. Hoerning A, Hegen B, Wingen AM, et al. Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients: a single-center experience. Pediatr Transplant 2012; 16:742-747.
67. Haagsma EB, van den Berg AP, Porte RJ, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008; 14:547-553.
68. Kamar N, Izopet J, Rostaing L. No reactivation of hepatitis E virus after kidney retransplantation. Am J Transplant 2012; 12:507-508.
69. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358:811-817.
70. Suneetha PV, Pischke S, Schlaphoff V, et al. HEV-specific T-cell responses are associated with control of HEV infection. Hepatology (Baltimore, Md) 2012; 55:695-708.
71. Kamar N, Legrand-Abravanel F, Dalton HR, Izopet J. Hepatitis E virus-specific T-cell response after transplantation. Hepatology (Baltimore, Md) 2012; 55:1643; author reply 4.
72. Lhomme S, Abravanel F, Dubois M, et al. HEV quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients. J Virol 2012; 86:100006-100014.
73. Moal V, Textoris J, Ben Amara A, et al. Chronic hepatitis E virus infection is specifically associated with an interferon-related transcriptional program. J Infect Dis 2013; 207:125-132.
74. Dong C, Zafrullah M, Mixson-Hayden T, et al. Suppression of interferon-alpha signaling by hepatitis E virus. Hepatology (Baltimore, Md) 2012; 55:1324-1332.
75. Dalton HR, Bendall R, Keane F, et al. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009; 361:1025-1027.
76. Kenfak-Foguena A, Schoni-Affolter F, Burgisser P, et al. Hepatitis E virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 2011; 17:1074-1078.
77. Kaba M, Richet H, Ravaux I, et al. Hepatitis E virus infection in patients infected with the human immunodeficiency virus. J Med Virol 2011; 83:1704-1716.
78. Jardi R, Crespo M, Homs M, et al. HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain. HIV Med 2012; 13:379-383.
79. Colson P, Kaba M, Moreau J, Brouqui P. Hepatitis E in an HIV-infected patient. J Clin Virol 2009; 45:269-271.
80. Shukla P, Nguyen HT, Torian U, et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci USA 2011; 108:2438-2443.
81. Nguyen HT, Torian U, Faulk K, et al. A naturally occurring human/hepatitis E recombinant virus predominates in serum but not in faeces of a chronic hepatitis E patient and has a growth advantage in cell culture. J Gen Virol 2012; 93 (Pt 3):526-530.
82. Peron JM, Mansuy JM, Recher C, et al. Prolonged hepatitis E in an immu-nocompromised patient. J Gastroenterol Hepatol 2006; 21:1223-1224.
83. Ollier L, Tieulie N, Sanderson F, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009; 150:430-431.
84. Tavitian S, Peron JM, Huynh A, et al. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J Clin Virol 2010; 49:141-144.
85. Alric L, Bonnet D, Laurent G, et al. Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-alpha therapy. Ann Intern Med 2010; 153:135-136.
86. Mallet V, Nicand E, Sultanik P, et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010; 153:85-89.
87. Alric L, Bonnet D, Beynes-Rauzy O, et al. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. Am J Gastroenterol 2011; 106:1562-1563.
88. Gauss A, Wenzel JJ, Flechtenmacher C, et al. Chronic hepatitis E virus infection in a patient with leukemia and elevated transaminases: a case report. J Med Case Rep 2012; 6:334.
89. Knoenecke C, Pischke S, Heim A, et al. Chronic hepatitis E in hematopoietic stem cell transplant patients in low-endemic country. Transplant Infect Dis 2012; 14:103-106.
90. Abravanel F, Mansuy JM, Huynh A, et al. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol 2012; 54:152-155.
91. Halac U, Beland K, Lapierre P, et al. Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant. J Pediatr 2012; 160:871.e1-874.e1.
92. le Coutre P, Meisel H, Hofmann J, et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009; 58:699-702.
93. Cheung MC, Maguire J, Carey I, et al. Review of the neurological manifestations of hepatitis E infection. Ann Hepatol 2012; 11:618-622.
94. Kamar N, Bendall RP, Peron JM, et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011; 17:173-179.
95. Del Bello A, Arne-Bes MC, Lavayssiere L, Kamar N. Hepatitis E virus-induced severe myositis. J Hepatol 2012; 57:1152-1153.
96. Kamar N, Izopet J, Cintas P, et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant 2010; 10:1321-1324.
97. Maurissen I, Jeurissen A, Strauven T, et al. First case of antiganglioside GM1-positive Guillain-Barre syndrome due to hepatitis E virus infection. Infection 2012; 40:323-326.
98. Cronin S, McNicholas R, Kavanagh E, et al. Antiglycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection. Ir J Med Sci 2011; 180:255-257.
99. Ali G, Kumar M, Bali SK, Wadhwa WB. Hepatitis E associated immune thrombocytopenia and membranous glomerulonephritis. Indian J Nephrol 2001; 11:70-72.
100. Kamar N, Mansuy JM, Esposito L, et al. Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient. Am J Kidney Dis 2005; 45:193-196.
101. Kamar N, Weclawiack H, Guilbeaud-Frugier C, et al. Hepatitis E virus and the kidney in solid-organ-transplant patients. Transplantation 2012; 93:617-623.
102. Sinha S, Jha R, Lakhtakia S, Narayan G. Acute pancreatitis following kidney transplantation: role of viral infections. Clin Transplant 2003; 17:32-36.
103. Bhagat S, Wadhawan M, Sud R, Arora A. Hepatitis viruses causing pancreatitis and hepatitis: a case series and review of literature. Pancreas 2008; 36:424-427.
104. Thapa R, Biswas B, Mallick D, Ghosh A. Acute pancreatitis: complicating hepatitis E virus infection in a 7-year-old boy with glucose 6 phosphate dehydrogenase deficiency. Clin Pediatr (Phila) 2009; 48:199-201.
105. Deniel C, Coton T, Brardjanian S, et al. Acute pancreatitis: a rare complication of acute hepatitis E. J Clin Virol 2011; 51:202-204.
106. Colson P, Payraudeau E, Leonnet C, et al. Severe thrombocytopenia associated with acute hepatitis E virus infection. J Clin Microbiol 2008; 46:2450-2452.
107. Fourquet E, Mansuy JM, Bureau C, et al. Severe thrombocytopenia associated with acute autochthonous hepatitis E. J Clin Virol 2010; 48:73-74.
108. Shah SA, Lal A, Idrees M, et al. Hepatitis E virus-associated aplastic anaemia: the first case of its kind. J Clin Virol 2012; 54:96-97.
109. Kamar N, Rostaing L, Abravanel F, et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010; 50:e30-e33.
110. Haagsma EB, Riezebos-Brilman A, van den Berg AP, et al. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl 2010; 16:474-477.
111. Kamar N, Abravanel F, Garrouste C, et al. Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrol Dial Transplant 2010; 25:2792-2795.
112. Kamar N, Rostaing L, Abravanel F, et al. Ribavirin therapy inhibits viral replication in patients with chronic hepatitis E virus infection. Gastroenter-ology 2010; 139:1612-1618.
113. Chaillon A, Sirinelli A, De Muret A, et al. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J Heart Lung Transplant 2011; 30:841-843.
114. de Niet A, Zaaijer HL, Ten Berge I, et al. Chronic hepatitis E after solid organ transplantation. Neth J Med 2012; 70:261-266.
115. Dalton H, Keane F, Bendall R, et al. Treatment of chronic hepatitis E in a HIV positive patient. Ann Intern Med 2011; 155:479-480.
116. Peron JM, Dalton H, Izopet J, Kamar N. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? J Hepatol 2011; 54:1323-1324; author reply 4-5.
117. Gerolami R, Borentain P, Raissouni F, et al. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011; 52:60-62.
118. Goyal R, Kumar A, Panda SK, et al. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report. Antivir Ther 2012; 17:1091-1096.
119. Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356:895-903.
120. Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376:895-902.